IRIS
DE LEO, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 418
EU - Europa 197
AS - Asia 61
AF - Africa 4
SA - Sud America 1
Totale 681
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 401
CN - Cina 47
IT - Italia 43
NL - Olanda 35
SE - Svezia 24
IE - Irlanda 20
UA - Ucraina 20
FI - Finlandia 18
CA - Canada 17
FR - Francia 15
DE - Germania 13
IN - India 8
GB - Regno Unito 5
CI - Costa d'Avorio 4
TR - Turchia 4
GR - Grecia 2
IR - Iran 2
CZ - Repubblica Ceca 1
EC - Ecuador 1
NO - Norvegia 1
Totale 681
Salva come PNG Salva come JPEG
Città #
Chandler 99
Amsterdam 32
Jacksonville 26
Ashburn 21
Millbury 19
Princeton 17
Wilmington 16
Woodbridge 16
Ottawa 15
Nanjing 13
Beijing 10
Naples 9
Boston 8
Napoli 7
Dearborn 5
Des Moines 5
Hebei 5
Nanchang 4
Jiaxing 3
Pune 3
San Mateo 3
Shenyang 3
Athens 2
Boardman 2
Catania 2
Changsha 2
Falls Church 2
Houston 2
Kronberg 2
Milan 2
New York 2
Norwalk 2
Pisa 2
Pittsburgh 2
Tianjin 2
Toronto 2
Villa Literno 2
Ailano 1
Ardabil 1
Bangalore 1
Buffalo 1
Castellammare di Stabia 1
Hangzhou 1
Indiana 1
Kunming 1
Lanzhou 1
Leawood 1
Los Angeles 1
Manta 1
Middletown 1
Mugnano Di Napoli 1
Mumbai 1
Ningbo 1
Oslo 1
Prague 1
Quindici 1
Redmond 1
Redwood City 1
San Diego 1
Seattle 1
Segrate 1
Washington 1
Yellow Springs 1
Totale 395
Salva come PNG Salva come JPEG
Nome #
Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism 57
Weekly clodronate treatment prevents bone loss and vertebral fractures in womenwith subclinical Cushing's syndrome. 56
GH INSUFFICIENCY IN OBESE PATIENTS. 55
Neuropsychiatric disorders in Cushing's syndrome. 53
The Treatment of Cushing's Disease. 48
The treatment with pasireotide in Cushing's disease: effects of long-term treatment on tumor mass in the experience of a single center. 42
Erratum to: The treatment with pasireotide in Cushing’s disease: effects of long–term treatment on tumor mass in the experience of a single center (Endocrine, (2015), 50, (725-740) DOI 10.1007/s12020-015-0557-2) 42
Metabolic alterations and cardiovascular outcomes of cortisol excess 41
Cushing's syndrome 37
Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: A retrospective, comparative, head-to-head study 37
Cardiovascular disease in Cushing's syndrome: heart versus vasculature. 35
Cushing’s disease: the burden of illness 35
The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery. 34
Pathophysiology of diabetes mellitus in Cushing's syndrome. 31
Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status. 31
New perspectives in the medical treatment of acromegaly 29
The Medical Treatment of Cushing's Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery 28
The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission. 24
Totale 715
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.498
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.498
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 1 0 2
2019/202085 30 0 4 0 5 7 3 3 1 6 9 17
2020/202163 0 4 7 4 4 14 5 0 9 1 15 0
2021/2022141 3 0 0 3 2 16 1 2 25 9 40 40
2022/2023227 17 4 6 27 32 27 1 28 44 35 5 1
2023/202469 4 13 4 15 3 6 6 10 4 4 0 0
Totale 715